How Much Does a Pharmacy Consultant Cost? Reconciliation, Coaching and Appraisal Prices

Twelve months of each invoice, added up

A monthly fee looks small beside a one-time price until it is multiplied by the months it really runs. Arithmetic from the pages above, for one store over one year:

• eRecon: $1,908.
• RxDelta: $2,388 on Data Access, $4,788 on Inventory Specialist at its regular price, $9,588 on Managed Reporting.
• DiversifyRx: $2,400 on Basic at $200 a month, or $3,600 at $300; $6,000 on Essentials; $18,000 on Unlimited.
• Titan Accounting Advisors’ Standard tier: $18,000.
• PAAS National’s Audit Assistance Service: $559, or $1,118 at that yearly price for the two-year membership required once an audit is under way.
• The Medicine Shoppe’s franchise fee: $7,188 a year, and $35,940 over the five-year agreement if it runs to term.

Two costs never reach those invoices. One is the pharmacist-owner’s own hours on coaching calls, file uploads and report reviews, taken from the bench or from the evening. The other is overlap: a store that gets reconciliation reports from its PSAO, pays for a reconciliation subscription and has its accountant track DIR fees may be paying more than once for the same match. The Review has no monthly line to total; it is paid once, and anything after it is priced separately or not bought at all.

Paid as promised, worth filling, still owed: what a reconciliation tool is built for

Reconciliation asks whether each payer paid what the adjudicated claim said it would, and chases the gap when it did not. That is worth knowing, and it is a narrower question than whether the claim was worth filling. A claim can be paid to the penny and still pay less than the pharmacy paid its wholesaler for the drug; seeing that takes the claims, by BIN, PCN, group and NDC, joined to the wholesaler’s purchase history and then totaled plan by plan.

Some money moves outside the claim altogether. Fees and clawbacks appear on remittances and PSAO statements after the fill and have to be matched back to the claims they came from before anyone can say what a plan really pays. And since January 1, 2026, the negotiated maximum fair prices of the Medicare Drug Price Negotiation Program have been in effect; CMS says a pharmacy using the Medicare Transaction Facilitator can receive the manufacturer’s refund through the facilitator’s payment module when that manufacturer has opted in to it, and can receive the remittance for refunds paid by paper check or as an X12 835 electronic remittance advice. Either way the refund is a receivable to watch: still owed until it lands.

So before comparing any two prices, write down which of the three questions is being paid for: paid as promised, worth filling, or still owed. Then ask each provider, subscription or adviser which of the three it answers, and in what form the answer arrives.

Per month, per recovery or fixed: who carries the risk in a pharmacy contract

Each way of charging moves risk between the pharmacy and the adviser. None makes anyone dishonest; each pulls in a direction worth seeing before signing. The gap between a consultant’s wage and the fee a firm bills, with federal pay data, is laid out in How Much Does a Business Consultant Cost?, linked below.

• Per month. A subscription or membership pays for access. It suits a standing job, such as matching remittances every week, and drifts in a month with no named task. Total it over the months it will really run.
• Per franchise term. A license fee pays for a brand, a network and the services attached to them for years. Read the term, the out clause and what the fee covers before treating the included consultant as a bonus.
• Per recovery or rebate. A fee set as a share of recovered underpayments, rebates or savings rewards volume and lets the adviser set the baseline it is measured from. Tied to rebates, it also ties the adviser to the wholesaler or buying group being recommended, so the pharmacy’s attorney reads that contract first.
• Per hour. None of the pharmacy pages read here printed a rate. If an adviser quotes one, get the expected hours and a ceiling on them in writing; without both, an overrun is the pharmacy’s to pay.
• Per project, fixed. Here the adviser absorbs any overrun on its own estimate, so the pull is toward finishing. That helps the pharmacy only if the questions, the stores and the files in scope are listed before work starts.

Stores, dispensing systems and the compounding lab: what moves a quote

Store count moves a quote first, because each location brings its own claims, its own wholesaler account and its own payer mix. The dispensing system comes next. A pharmacy that can export claims by BIN, PCN, group and NDC in an afternoon, and receives 835s and PSAO reconciliation reports as files, is cheaper to read than one whose remittances arrive on paper and whose fee statements sit in an inbox, since somebody has to rebuild that record before counting can start. A compounding lab adds a costing job of its own: ingredients, supplies and technician time for each preparation. Scope and urgency come last.

Warning signs in a pharmacy consulting offer

General checks on scope, price and exit terms sit in the ten-question guide to choosing an operations consultant, linked below. A pharmacy offer can fail in ways of its own:

• A margin, DIR or clawback recovery figure promised before anyone has opened a claims export.
• A fee measured as a share of rebates from a wholesaler or buying group that the same adviser recommends.
• A request for a dispensing-system login or patient-level data on day one. Under HIPAA, protected health information goes to a business associate only after the pharmacy has satisfactory assurance, set down in a written contract or other written agreement, that the information will be safeguarded (45 CFR 164.502(e)); a first look built on aggregate exports needs no patient names. Not legal advice.
• Audit help folded into a coaching or consulting package while a PBM audit letter is open. That letter goes to an audit-assistance service or a pharmacy attorney now.
• A business adviser offering to sign off on USP 797 or 800 readiness. Sterile and hazardous-drug compounding compliance belongs with a compliance specialist and the state board of pharmacy.

When to keep the money

Hiring nobody can be the right call. A remittance nobody opens, or a MAC appeal nobody files, needs one named person and a standing hour each week, not a study. A pharmacy that cannot cover its next wholesaler payment needs a decision about that payment before it needs any report. A pharmacist still weighing whether to buy a store needs an appraisal, a broker, a lender and an accountant; there are no claims of the buyer’s own to read yet.

An open PBM audit goes to a pharmacy attorney or an audit-assistance service first, and any review of the money waits until it is answered. Size matters too. The Review is priced for pharmacies with $1 million or more in yearly sales; below that line, the fee can outweigh anything the records turn up, and on the 20-minute call we say so before anyone pays.

The Review, inside a pharmacy

The Revenue Review reads aggregate exports a pharmacy already has — claims by plan, BIN, PCN and NDC, 835 remittances, PSAO and fee statements, wholesaler purchase history — with no patient names, and puts a monthly dollar figure, wherever the records support one, on below-cost plans, on fees and clawbacks matched to their claims, and on MFP refunds not yet received. Lumina is not a consultant pharmacist: the Review gives no clinical advice, defends no audit and sells no reconciliation software, and its scope, deposit and the documents the pharmacy keeps are on the Review page, linked below.